Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2008 1
2011 1
2013 1
2017 1
2022 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
Ytterberg SR, Bhatt DL, Mikuls TR, Koch GG, Fleischmann R, Rivas JL, Germino R, Menon S, Sun Y, Wang C, Shapiro AB, Kanik KS, Connell CA; ORAL Surveillance Investigators. Ytterberg SR, et al. N Engl J Med. 2022 Jan 27;386(4):316-326. doi: 10.1056/NEJMoa2109927. N Engl J Med. 2022. PMID: 35081280 Clinical Trial.
[Introducing the new editor of Reumatología Clínica].
Barile Fabris LA, Terán Estrada L, Úcar Angulo E. Barile Fabris LA, et al. Among authors: ucar angulo e. Reumatol Clin. 2011 Nov-Dec;7(6):351. doi: 10.1016/j.reuma.2011.10.007. Reumatol Clin. 2011. PMID: 22078691 Free article. Spanish. No abstract available.
SER consensus statement on the use of biologic therapy for systemic lupus erythematosus.
Calvo-Alén J, Silva-Fernández L, Úcar-Angulo E, Pego-Reigosa JM, Olivé A, Martínez-Fernández C, Martínez-Taboada V, Luis Marenco J, Loza E, López-Longo J, Gómez-Reino JJ, Galindo-Izquierdo M, Fernández-Nebro A, Cuadrado MJ, Aguirre-Zamorano MÁ, Zea-Mendoza A, Rúa-Figueroa I; Sociedad Española de Reumatología. Calvo-Alén J, et al. Among authors: ucar angulo e. Reumatol Clin. 2013 Sep-Oct;9(5):281-96. doi: 10.1016/j.reuma.2013.04.001. Epub 2013 Jul 17. Reumatol Clin. 2013. PMID: 23871156 Free article. English, Spanish.
Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials.
Clowse ME, Wallace DJ, Furie RA, Petri MA, Pike MC, Leszczyński P, Neuwelt CM, Hobbs K, Keiserman M, Duca L, Kalunian KC, Galateanu C, Bongardt S, Stach C, Beaudot C, Kilgallen B, Gordon C; EMBODY Investigator Group. Clowse ME, et al. Arthritis Rheumatol. 2017 Feb;69(2):362-375. doi: 10.1002/art.39856. Arthritis Rheumatol. 2017. PMID: 27598855 Free PMC article. Clinical Trial.
[Comorbidity of systemic lupus erythematosus].
Ucar Angulo E, Rivera García N. Ucar Angulo E, et al. Reumatol Clin. 2008 Mar;4 Suppl 1:17-21. doi: 10.1016/S1699-258X(08)76134-5. Epub 2009 Feb 3. Reumatol Clin. 2008. PMID: 21794548 Free article. Spanish.